PASI

2 stories · following the connections

Business

Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis

By Nasdaq OMXMar 6, 2017, 1:31 PM UTC

Business

Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis

By Nasdaq OMXMar 6, 2017, 1:31 PM UTC